Zogenix Tumbles on Fears Its Pain Drug May Lose Out to a Rival
Shares of Zogenix fell as much as 26% on Wednesday after a rival pharmaceutical company said it will seek regulatory approval of a tamper-proof version of Zogenix's powerful new pain drug.